According to Fixygen, shareholders of Indar Insulin Manufacturing PJSC will consider the issue of terminating the powers of the chairman and members of the company’s supervisory board at an extraordinary general meeting on June 16.
According to a statement from the State Property Fund of Ukraine, the meeting will be held remotely via a poll.
The agenda also includes the election of a new supervisory board, the approval of the terms of civil law contracts with its members, and the appointment of an authorized representative to sign such contracts.
The list of shareholders entitled to participate in the meeting is current as of June 11, 2026.
Indar PJSC is registered in Kyiv. The company specializes in the production of insulins and medications for the treatment of diabetes.
